Hot Flasher

Hot Flasher
  • 5.0 (2)
  • Sexuality
  • Updated Daily

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

  1. 1d ago

    Why Your Symptoms Hit Harder (And What Your Brain Has to Do With It)

    This episode digs into why some women have significantly worse menopause symptoms than others, looks at the surprisingly plausible case for antihistamines as a symptom tool, and breaks down what a new SWAN study says about midlife inflammation and your future memory. Key Takeaways: • A newly identified biological difference — in how certain women's nervous systems respond to dropping estrogen — may explain why symptom severity varies so much from person to person. • Antihistamines target histamine, a chemical that interacts with the same brain pathways involved in hot flashes and mood swings; the evidence is early but the mechanism is real. • A study from the long-running SWAN research project found that women with higher levels of a specific inflammation marker (GlycA) in midlife had lower working memory scores years later. • Not all inflammation signals worked the same way — two immune proteins (complement C3 and C4) were actually associated with better cognitive outcomes when they increased, which complicates the "all inflammation is bad" narrative. • The SWAN finding points to midlife — not just post-menopause — as a window that may matter for long-term brain health. Sources & References: • Scientists discovered one reason menopause symptoms might be worse for certain women (https://news.google.com/rss/articles/CBMiiAFBVV95cUxNRXJld3p2V09adzdLdk83cUNMMlFnbnlodngxeERaZUJrVFdMV1BFa191TEN4WVZnMjcxc1VYYkJ0YlFhNXVocmFtUDJDby13Sl9Pa0tCQkxJUnoyek03Tlk5RDRSWG50Qks1Y0N2NmlDeHJkeGdrV1ViM2pDcFFZdHhKWXVVTE9q?oc=5) - Women's Health • Can antihistamines really help with PMDD and menopausal symptoms? (https://news.google.com/rss/articles/CBMihAFBVV95cUxNa0Y1bzRYMlZDUlJlamVjZTJjWEZSd1QzMTFVbDBwR1ZPcDcxRGF4ODNxd0lSNUtiQ0dGZXRsNTAzOGFqWVJ6VTVfOGVOU2VZZzRwY2NwVkFZRnRwU1p6Y2RXWUtnTlVRLTZ6eWFwOVV6RzJxUERpSFhzQUZ1cTVXdXEtQlQ?oc=5) - The Guardian • Inflammatory and immune biomarkers over midlife and future cognition in women: the SWAN HDL Ancillary Study (https://pubmed.ncbi.nlm.nih.gov/42549661/) - NAMS Journal / PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-18-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  2. 2d ago

    Your Brain, Your Bones, and Your Period Tracker Just Sold Your Data

    This episode covers three research and news stories: a new study suggesting hormone therapy may reduce Alzheimer's risk by around 35%, a major meta-analysis confirming that strength training does protect bone density after menopause (with some important caveats on how big that effect actually is), and a data privacy investigation finding that menopause apps have been selling users' intimate health information — and in many cases, still are. Key Takeaways: • A new study found that women who used hormone therapy had roughly 35% lower Alzheimer's risk — but this is observational research, not a clinical trial, and the result does not mean HRT prevents Alzheimer's. • A systematic review of multiple studies found that high-intensity and strength training does increase bone density in postmenopausal women, though the effect sizes were described as small — real, but not dramatic. • The type of exercise matters: impact training (like jumping) and strength training both showed benefits for bone density, and the research supports combining them rather than choosing one. • Multiple menopause apps have sold users' intimate health data — including symptom logs, cycle history, and other private details — often without clear disclosure, and the practice is reportedly ongoing. • If you use a menopause or period tracking app, it is worth checking its privacy policy specifically for language about data sharing with third parties or "partners." Sources & References: • Alzheimer's risk may be 35% lower with common menopause treatment, study finds (https://news.google.com/rss/articles/CBMipAFBVV95cUxPR2M3NVFTQktWaW5Pc3dMcWNwZnNfUnhtaGRnZlpwSHIzUjNUU1JmaTZ5aFdsWnl1WXRaQ2R1YlYyMm5wWmVkdGc3bHkxSjI5ekpHdVUzMExoX1hDRllScHcwX3ZBSnJUVVItNFZzeFZRcUZTUGtjbElZc0dpTkU1ekdzLXhXcHNBcUd5VExRUEVWSzZ6ZUM3dWFPYVNYVlpNUmY4RdIBqgFBVV95cUxQQm5Gd3F0S01iejNscTdTcDNEZEhQeGNadGJNV1VMRnVwMG1peUVOakkzeDRZZDFrNVdXaXF5YkUwb1R1elUyanVkNHMtRVFjdDVtRlNtMDJsdU5iWVBNM3QzWHdfYl9SaHBCLWxnZWM4cHBmNzk2b09jSzBBZnNDMldjQ3hBVUl2bENHOUd6RjdpWFpkLXFnLUpWd3Z0M1NFUXNRN0Y0Tk5oZw) - Fox News • Systematic review and meta-analysis: high-intensity, impact, and strength training effects on bone density in pre- and postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42578477/) - Menopause (NAMS Journal) via PubMed • Millions of women's intimate health data has been sold by menopause apps — and it's still happening (https://news.google.com/rss/articles/CBMilAFBVV95cUxNTWlUVjlzbkdfVVQ2MTUxa29PWXo4WVk1RG9TRjk3UFpYbkVhb1JXbEpGeFA3bkdPWGpGeWRqaF9lTVFRdG9sbUtXUERKamdHdWZLUTNZRFRGZFJDOG1sY1VYTjRTRTBDNTVXaGRiU3FXQUlHS0tuQldYdDJtV2xHSEZxODdwUjRoa1lFRnVuektnZ1Q2) - The Independent Listen with full show notes: https://hotflasher.com/episodes/2026-08-17-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  3. 5d ago

    Your Chest X-Ray Might Know Your Bones Better Than You Do

    This episode covers two new approaches to catching osteoporosis earlier in postmenopausal women — one using AI analysis of routine chest X-rays, one using a clinical prediction tool called a nomogram — plus a look at a newly defined syndrome called PMOS that links ovarian, metabolic, and cardiovascular risk in ways medicine is only beginning to map. All three studies published in August 2026. Key Takeaways: • A new AI tool can analyze routine chest X-rays to flag women who may need osteoporosis evaluation earlier — no additional scan required. • A separately published nomogram offers a scoring model to help predict postmenopausal osteoporosis risk using clinical variables. • Postmenopausal women with polycystic ovary syndrome (PCOS) history may carry elevated cardiometabolic risk under a newly proposed framework called PMOS. • Most women don't get a baseline DEXA scan until age 65 — both the AI screening tool and the nomogram are attempts to close that gap. • The PMOS research signals that PCOS doesn't simply disappear after menopause; its metabolic fingerprint may persist and compound cardiovascular risk. Sources & References: • Construction and validation of a nomogram for diagnosing postmenopausal osteoporosis (https://pubmed.ncbi.nlm.nih.gov/42596822/) - PubMed • AI-derived opportunistic screening using chest radiographs to identify bone mineral density patterns (https://pubmed.ncbi.nlm.nih.gov/42595903/) - PubMed • Cardiometabolic risk in postmenopausal women with polyendocrine metabolic ovarian syndrome (PMOS) (https://pubmed.ncbi.nlm.nih.gov/42595557/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-14-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  4. 6d ago

    Fibroids, Fatty Liver, and Bones — Your Body Has Notes

    This episode covers three studies published in August 2026 touching on fibroid care in the perimenopausal transition, fatty liver disease risk accumulation in postmenopausal women, and what standard DXA bone scans may not be capturing about bone metabolism. Nykki examines what the research actually says, where the gaps are, and why these conditions intersect with menopause more than most clinicians discuss. Key Takeaways: • Uterine fibroids (leiomyomas) affect up to 70-80% of women by age 50, but treatment decisions are still largely one-size-fits-all rather than tailored to symptom phenotype, reproductive stage, or long-term goals. • A 2026 study found that in postmenopausal women, it's not just body fat but the accumulation of multiple cardiometabolic risk factors together — insulin resistance, dyslipidemia, hypertension — that predicts more severe hepatic steatosis (fatty liver). • Standard DXA scans measure bone density but don't capture bone turnover rate — how fast bone is being broken down and rebuilt — which matters especially during and after menopause when that rate accelerates. • Bone turnover markers (blood and urine tests) can give a more dynamic picture of skeletal health than a single DXA reading, and research suggests they may be underused in routine postmenopausal care. • Women with multiple cardiometabolic risk factors after menopause may warrant liver screening conversations with their doctors, even in the absence of symptoms. Sources & References: • From prevalence to precision: Integrating phenotype, symptoms, reproductive goals, and treatment in leiomyoma care (https://pubmed.ncbi.nlm.nih.gov/42590871/) - PubMed • Adiposity and cumulative cardiometabolic risk factors as determinants of hepatic steatosis severity in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42590200/) - PubMed • Bone turnover markers, DXA and mineral metabolism in long-term kidney transplant recipients: a cross-sectional comparative study (https://pubmed.ncbi.nlm.nih.gov/42590077/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-13-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  5. Aug 12

    Flaxseed, Fake Diagnoses, and the Five-Minute Menopause Appointment

    Today's episode looks at a new flaxseed and Linusorb study claiming to ease menopausal symptoms through non-hormonal estrogen receptor activation, a rare breast cancer case report with a warning relevant to anyone in or around menopause, and new quality-improvement research on why menopause conversations in primary care are still falling short — and what's actually being done about it. Key Takeaways: • A new study found flaxseed and Linusorb may reduce menopausal symptoms and bone loss by activating estrogen receptors non-hormonally, but the evidence base is early and the leap from mechanism to clinical recommendation is a long one. • Metastatic breast cancer can spread to the cervix and endometrium and look exactly like a primary gynecologic cancer — a case report published today is a reminder that unusual gynecologic symptoms always warrant thorough workup, not assumptions. • A 2026 quality improvement project found that structured tools and checklists in primary care significantly increased the rate of menopause conversations — but the fact that we need a QI project to get doctors talking about menopause tells its own story. • Research on phytoestrogens remains genuinely mixed; the women most likely to benefit from dietary interventions appear to be those who produce equol, a compound not everyone's gut microbiome can make from lignans. • The average primary care appointment is not designed for menopause — it's a condition that spans sleep, mood, bone health, cardiovascular risk, and more, and five minutes doesn't get you there. Sources & References: • Flaxseed and Linusorb synergistically ameliorate menopausal symptoms through non-hormonal activation of estrogen receptors (https://pubmed.ncbi.nlm.nih.gov/42581697/) - PubMed • Metastatic breast cancer to the cervix and endometrium mimicking a primary gynecologic malignancy (https://pubmed.ncbi.nlm.nih.gov/42581665/) - PubMed • Facilitating menopause discussions in primary care: a quality improvement project (https://pubmed.ncbi.nlm.nih.gov/42580869/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-12-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  6. Aug 11

    Your Lungs, Your Brain, and the Guidelines That Forgot You Exist

    This episode looks at three new papers: one connecting diet, insulin resistance, and a specific kind of lung impairment in postmenopausal women; one calling out psychiatric treatment guidelines for failing midlife women during menopause; and one mouse study on a traditional Chinese herbal formula and its effects on brain inflammation. Nykki reads the methods, names what the evidence actually supports, and is direct about where each study falls short or raises something worth watching. Key Takeaways: • A 2026 cross-sectional study found that lower dietary quality in postmenopausal women was associated with a specific lung function pattern called PRISm — and insulin resistance appears to be part of the mechanism connecting diet to lung impairment. • Cross-sectional studies cannot establish cause and effect — they show association, not direction — so this finding is hypothesis-generating, not actionable on its own. • Australia and New Zealand's psychiatric guidelines for schizophrenia largely ignore how menopause affects antipsychotic medication needs, leaving midlife women undertreated or incorrectly dosed at a critical biological transition. • A 2026 mouse study found that the Chinese herbal formula Chaihu Shugan San reduced neuroinflammation and improved markers of hippocampal function — but mice are not humans, and the pathway from animal model to clinical use is long and frequently fails. • The schizophrenia guideline gap reflects a systemic problem in medicine: women's health is often studied as a deviation from a male default, and life-stage changes like perimenopause are treated as edge cases rather than core clinical variables. Sources & References: • Dietary quality, insulin resistance, and lung function in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42577152/) - PubMed • RANZCP schizophrenia guidelines and the unmet needs of midlife women (https://pubmed.ncbi.nlm.nih.gov/42576669/) - PubMed • Chaihu Shugan San, microglial polarization, and hippocampal plasticity in menopausal mice (https://pubmed.ncbi.nlm.nih.gov/42576491/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-11-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  7. Aug 10

    Your Brain, Your Gut, and the Doctor Who Wasn't Taught Either

    This episode covers three new papers from the NAMS journal: a SWAN ancillary study connecting midlife inflammatory biomarkers to future working memory, a randomized controlled trial on a probiotic formula for menopausal symptoms, and a narrative review exposing what medical schools are — and mostly aren't — teaching about menopause. Research credibility and medical-system frustration lenses throughout. Key Takeaways: • Higher baseline GlycA (an inflammatory glycoprotein marker) was associated with lower future working memory in the SWAN HDL Ancillary Study — suggesting midlife inflammation may be a modifiable risk factor for cognitive decline. • Complement proteins C3 and C4 showed a more complex picture: higher baseline complement factor 4 and increases in both C3 and C4 over time appeared cognitively protective, complicating a simple "less inflammation = better brain" narrative. • A randomized controlled trial found a probiotic formula was associated with improvements in menopausal symptoms and quality of life — a real RCT result, not a supplement ad, though the researchers acknowledge more work is needed to confirm mechanism. • A narrative review of undergraduate medical curricula found that menopause education remains inconsistent, under-resourced, and frequently absent — meaning the knowledge gap starts well before residency. • The doctor who doesn't know how to counsel you on menopause very likely wasn't taught how. That's a systemic failure, not an individual one — and it has downstream consequences for every woman who hits perimenopause and gets a blank stare from her GP. Sources & References: • Inflammatory and immune biomarkers over midlife and future cognition in women: the SWAN HDL Ancillary Study (https://pubmed.ncbi.nlm.nih.gov/42549661/) - PubMed / Menopause (NAMS Journal) • Efficacy of a probiotic formula in the management of menopausal symptoms and quality of life: a randomized controlled trial (https://pubmed.ncbi.nlm.nih.gov/42549656/) - PubMed / Menopause (NAMS Journal) • Menopause education in undergraduate medical curricula: a narrative review of teaching models, content gaps, and learner preparedness (https://pubmed.ncbi.nlm.nih.gov/42517363/) - PubMed / Menopause (NAMS Journal) Listen with full show notes: https://hotflasher.com/episodes/2026-08-10-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  8. Aug 7

    Coffee, Bones, and the Ultrasound Finding You Should Know About

    This Friday episode covers three new studies: a Turkish study on coffee and hot flash severity, a bone density trial testing a specific form of vitamin D in postmenopausal women with osteopenia, and Indonesian ultrasound research that highlights an endometrial thickness measurement every postmenopausal woman deserves to understand. Lenses used: research credibility and lifestyle. Key Takeaways: • A 2026 Turkish study (Akbal et al.) found an association between coffee consumption and vasomotor symptom severity in postmenopausal women — but the study is observational, so correlation doesn't equal causation. • Doxercalciferol (1α-hydroxyvitamin D2) showed measurable effects on spine and femur bone mineral density in postmenopausal women with osteopenia in a 2026 trial by Gallagher — worth asking your provider about if standard vitamin D supplementation hasn't moved your numbers. • Endometrial thickness on ultrasound is a key screening marker: in postmenopausal women, a measurement above 4–5mm typically prompts further investigation, and the 2026 Indonesian study (Putra et al.) reinforces why baseline imaging matters across diverse populations. • Not all vitamin D is the same — doxercalciferol is an activated precursor form that may act differently in the body than standard D3 supplements, which is relevant if you're managing bone density numbers. • If you drink coffee and your hot flashes are severe, this study gives a reasonable prompt to experiment — track your symptoms for two weeks with and without, then decide based on your own data. Sources & References: • Doxercalciferol and bone mineral density in postmenopausal osteopenic women (https://pubmed.ncbi.nlm.nih.gov/42564695/) - PubMed • Endometrial thickness evaluation by ultrasound in multi-ethnic Indonesian women (https://pubmed.ncbi.nlm.nih.gov/42564625/) - PubMed • Coffee consumption and vasomotor symptom severity in Turkish postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42564606/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-08-07-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

See All (104)

Ratings & Reviews

5
out of 5
2 Ratings

About

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

Information

  • Creator
    Hot Flasher
  • Years Active
    2026
  • Episodes
    104
  • Rating
    Clean
  • Show Website
    Hot Flasher